ReproCELL, Inc.

ReproCELL, Inc. has faced significant stock volatility, dropping nearly 10% today and over 23% in the past month. The company's financial metrics reveal a decline in net sales and pre-tax profits, with a low return on equity. Its market capitalization stands at JPY 16,746 million amid industry challenges.

ReproCELL, Inc. has faced notable challenges, with a significant stock decline and poor financial metrics, including a drop in net sales and pre-tax profits. Despite a modest year-to-date gain, the company's long-term performance has been disappointing compared to the broader market, particularly the Japan Nikkei 225 index.

ReproCELL, Inc. has faced a notable stock decline amid a challenging market, with a significant drop in net sales and pre-tax profits. Despite a recent positive monthly trend, its one-year performance lags behind the broader market. The company grapples with low profitability and a high P/E ratio.

ReproCELL, Inc. has seen a significant increase in its stock price today, contrasting with the modest rise of the Japan Nikkei 225. Despite a strong monthly performance, the company faces challenges with declining net sales and profits, while its long-term performance remains underwhelming compared to the broader market.

ReproCELL, Inc. has seen a significant rise in its stock performance, gaining 7.65% on February 25, 2026, despite a decline in the Japan Nikkei 225. However, the company faces challenges with a notable decrease in net sales and pre-tax profit, alongside a low return on equity.